Skip to content

Clinical trials

Withdrawn Observational Hemorrhage trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Observational Status: Withdrawn Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20122
20131
20162
20181
20191
20201
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Baki Topal1
Boehringer Ingelheim1
Cardioangiologisches Centrum Bethanien1
Innovative Trauma Care Inc.1
Montefiore Medical Center1
Sunnybrook Health Sciences Centre1
University of California, San Francisco1
University of Minnesota1
Wake Forest University Health Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage12
Thrombosis2
Alzheimer Disease1
Cerebral Amyloid Angiopathy1
Heart Failure1
Hemostatic Disorders1
Ischemic Stroke1
Neoplasms1
Pancreatic Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.